AprilBio Co.,Ltd. (KOSDAQ:397030)

Market Cap	492.23B
Revenue (ttm)	29.69B
Net Income (ttm)	22.63B
Shares Out	22.53M
EPS (ttm)	1,022.72
PE Ratio	21.36
Forward PE	68.28
Dividend	n/a
Ex-Dividend Date	n/a

Volume	238,402
Average Volume	282,148
Open	21,900
Previous Close	21,850
Day's Range	21,500 - 22,250
52-Week Range	11,980 - 25,900
Beta	1.54
RSI	61.32
Earnings Date	n/a

About AprilBio

AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics. The company develops products based on its long-acting protein medicine platform technology. It is developing various products for use in the treatment of rare diseases, cancer, male infertility, autoimmune and inflammatory diseases. The company was founded in 2013 and is headquartered in Chuncheon-si, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2013
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 397030